Sophia Genetics Sa (SOPH)

$4.57 -0.03 (-0.65%)
Market Cap 310.87M
Revenue (ttm) 65.17M
Net Income (ttm) -62.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -95.89%
Debt to Equity Ratio 0.78
Volume 59,200
Avg Vol 199,634
Day's Range N/A - N/A
Shares Out 67.58M
Stochastic %K 19%
Beta 1.11
Analysts Strong Sell
Price Target $7.67

Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switze...

Industry: Health Information Services
Sector: Healthcare
Phone: 41 21 694 10 60
Address:
La PiEce 12, Rolle, Switzerland
MelissaMcgray930
MelissaMcgray930 Feb. 21 at 6:51 AM
$SOPH Sophiris Bio develops urology treatments. Clinical outcomes drive valuation. Early-stage risk remains high.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 6:10 PM
$SOPH RSI: 32.90, MACD: -0.0713 Vol: 0.25, MA20: 4.97, MA50: 4.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bigreaper
Bigreaper Feb. 10 at 4:38 PM
$SOPH https://www.stocktitan.net/news/SOPA/society-pass-and-nusa-trip-collaborate-with-trip-ninja-to-expand-8ocjcj2sx77n.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 11:45 PM
$SOPH RSI: 56.91, MACD: 0.1580 Vol: 0.28, MA20: 5.11, MA50: 4.84 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 4:04 PM
$SOPH Share Price: $5.61 Contract Selected: Jun 18, 2026 $5 Calls Buy Zone: $0.51 – $0.63 Target Zone: $0.86 – $1.05 Potential Upside: 59% ROI Time to Expiration: 145 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jan. 19 at 7:48 PM
$SOPH (monthly) $350M mc founder-led $XLV name rotating up to 1.5-year highs on volume above freshly rising 10/20/40-month SMAs - Volume on monthly chart since August confirming the move in price - Pct of all funds at nearly 3-year highs - Just 252 watcher on Stocktwits TrendEdge.app/asset/SOPH
0 · Reply
History101
History101 Jan. 19 at 1:06 AM
$SOPH 251 watching 1/18/2026
0 · Reply
History101
History101 Jan. 19 at 1:06 AM
$SOPH enormous volume on Fri, Jan 16, over 18x the 10d volume, enough to top the CNBC list of "unusual volume" stocks. The fact that SOPH was up only 5.6% imo means dark pool accumulation by large investors. Volume before price!!
0 · Reply
kshonstocks
kshonstocks Jan. 17 at 2:50 PM
love the vol bar on the $SOPH
0 · Reply
venice868
venice868 Jan. 16 at 4:24 PM
$SOPH what’s going on with the volume today
0 · Reply
Latest News on SOPH
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

Feb 25, 2026, 8:00 AM EST - 1 day ago

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

Feb 17, 2026, 8:00 AM EST - 9 days ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

Feb 10, 2026, 9:22 AM EST - 16 days ago

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

Jan 12, 2026, 7:00 AM EST - 6 weeks ago

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

Jan 7, 2026, 8:00 AM EST - 7 weeks ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

Nov 11, 2025, 9:00 AM EST - 3 months ago

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

Nov 11, 2025, 8:01 AM EST - 3 months ago

SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine

SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 1:56 PM EST - 4 months ago

SOPHiA GENETICS SA (SOPH) Q3 2025 Earnings Call Transcript

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

Nov 4, 2025, 6:45 AM EST - 4 months ago

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

Oct 21, 2025, 8:00 AM EDT - 4 months ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

Oct 16, 2025, 11:00 AM EDT - 4 months ago

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Oct 16, 2025, 4:01 AM EDT - 4 months ago

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:01 AM EDT - 5 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:00 AM EDT - 5 months ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

Sep 22, 2025, 8:00 AM EDT - 5 months ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

AZN

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

Sep 5, 2025, 4:00 AM EDT - 6 months ago

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:19 PM EDT - 7 months ago

SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript

SOPHiA GENETICS Reports Second Quarter 2025 Results

Aug 5, 2025, 6:45 AM EDT - 7 months ago

SOPHiA GENETICS Reports Second Quarter 2025 Results

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Aug 5, 2025, 6:40 AM EDT - 7 months ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

AZN

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 7 months ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:05 AM EDT - 10 months ago

SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript

SOPHiA GENETICS Reports First Quarter 2025 Results

May 6, 2025, 6:45 AM EDT - 10 months ago

SOPHiA GENETICS Reports First Quarter 2025 Results

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

Apr 28, 2025, 12:00 PM EDT - 10 months ago

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

AZN

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Apr 22, 2025, 8:00 AM EDT - 11 months ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

Apr 8, 2025, 2:00 AM EDT - 11 months ago

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

Mar 18, 2025, 9:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 2:32 PM EST - 1 year ago

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Mar 4, 2025, 6:45 AM EST - 1 year ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

Feb 24, 2025, 4:00 AM EST - 1 year ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AZN

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

Feb 18, 2025, 8:30 AM EST - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

Jan 28, 2025, 8:46 AM EST - 1 year ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Nov 21, 2024, 5:30 AM EST - 1 year ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 2:46 PM EST - 1 year ago

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Nov 5, 2024, 6:32 AM EST - 1 year ago

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

SOPHiA GENETICS Reports Third Quarter 2024 Results

Nov 5, 2024, 6:30 AM EST - 1 year ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Oct 22, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Sep 14, 2024, 9:00 AM EDT - 1 year ago

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Sep 12, 2024, 7:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Sep 12, 2024, 4:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

Sep 10, 2024, 10:16 AM EDT - 1 year ago

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

AZN

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Sep 5, 2024, 8:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

Sep 4, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Aug 28, 2024, 1:30 PM EDT - 1 year ago

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

SOPHiA DDM™ Platform Certified Under IVDR

Aug 14, 2024, 3:00 AM EDT - 1 year ago

SOPHiA DDM™ Platform Certified Under IVDR

SOPHiA GENETICS Reports Second Quarter 2024 Results

Aug 6, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports Second Quarter 2024 Results

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

Jul 29, 2024, 10:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 11:59 AM EDT - 1 year ago

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

Jul 23, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

Jul 4, 2024, 2:30 AM EDT - 1 year ago

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

MelissaMcgray930
MelissaMcgray930 Feb. 21 at 6:51 AM
$SOPH Sophiris Bio develops urology treatments. Clinical outcomes drive valuation. Early-stage risk remains high.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 6:10 PM
$SOPH RSI: 32.90, MACD: -0.0713 Vol: 0.25, MA20: 4.97, MA50: 4.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bigreaper
Bigreaper Feb. 10 at 4:38 PM
$SOPH https://www.stocktitan.net/news/SOPA/society-pass-and-nusa-trip-collaborate-with-trip-ninja-to-expand-8ocjcj2sx77n.html
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 28 at 11:45 PM
$SOPH RSI: 56.91, MACD: 0.1580 Vol: 0.28, MA20: 5.11, MA50: 4.84 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 23 at 4:04 PM
$SOPH Share Price: $5.61 Contract Selected: Jun 18, 2026 $5 Calls Buy Zone: $0.51 – $0.63 Target Zone: $0.86 – $1.05 Potential Upside: 59% ROI Time to Expiration: 145 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Jan. 19 at 7:48 PM
$SOPH (monthly) $350M mc founder-led $XLV name rotating up to 1.5-year highs on volume above freshly rising 10/20/40-month SMAs - Volume on monthly chart since August confirming the move in price - Pct of all funds at nearly 3-year highs - Just 252 watcher on Stocktwits TrendEdge.app/asset/SOPH
0 · Reply
History101
History101 Jan. 19 at 1:06 AM
$SOPH 251 watching 1/18/2026
0 · Reply
History101
History101 Jan. 19 at 1:06 AM
$SOPH enormous volume on Fri, Jan 16, over 18x the 10d volume, enough to top the CNBC list of "unusual volume" stocks. The fact that SOPH was up only 5.6% imo means dark pool accumulation by large investors. Volume before price!!
0 · Reply
kshonstocks
kshonstocks Jan. 17 at 2:50 PM
love the vol bar on the $SOPH
0 · Reply
venice868
venice868 Jan. 16 at 4:24 PM
$SOPH what’s going on with the volume today
0 · Reply
DARKP00L
DARKP00L Jan. 12 at 12:16 PM
$SOPH 07:04 on Jan. 12 2026 SOPHiA GENETICS Reports Preliminary Q4 Revenue Of At Least $21M, Representing Increase Of ~20% YoY; FY25 Preliminary Revenue Of ~77M, Up ~18% YoY #tradeideas
0 · Reply
venice868
venice868 Jan. 9 at 6:40 PM
$SOPH m&a coming in?
0 · Reply
MIMI133
MIMI133 Jan. 9 at 6:28 PM
$SOPH Squeeze!
0 · Reply
MIMI133
MIMI133 Jan. 7 at 2:04 PM
$SOPH BRIEF-Sophia Genetics And MD Anderson Announce Collaboration To Accelerate Ai-Driven Precision Oncology 14:54 (07-01) - Bron: Reuters
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 2 at 10:24 AM
$SOPH RSI: 50.74, MACD: 0.0219 Vol: 0.11, MA20: 4.74, MA50: 4.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 15 at 2:43 PM
$SOPH Share Price: $4.60 Contract Selected: Jun 18, 2026 $5 Calls Buy Zone: $1.07 – $1.32 Target Zone: $1.99 – $2.43 Potential Upside: 75% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
stockanalysis_
stockanalysis_ Nov. 25 at 12:10 AM
After Hours Losers: $SNCR $KTTA $SOPH $SONM $LUD Bookmark this page: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 11 at 3:51 PM
$SOPH
0 · Reply
erevnon
erevnon Nov. 10 at 12:00 PM
BTIG maintains Sophia Genetics $SOPH at Buy and raises the price target from $6 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
anachartanalyst
anachartanalyst Nov. 10 at 10:01 AM
$SOPH https://anachart.com/wp-content/uploads/ana_temp/1762768870_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 9:52 AM
BTIG has adjusted their stance on Sophia Genetics ( $SOPH ), setting the rating to Buy with a target price of 6 → 7.
0 · Reply
zerodayrounder
zerodayrounder Nov. 1 at 3:09 PM
$SOPH good looking set up into EPS
0 · Reply